{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T19:10:05Z","timestamp":1685646605178},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.exphem.2010.06.007","type":"journal-article","created":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T09:09:38Z","timestamp":1277370578000},"page":"868-876.e1","source":"Crossref","is-referenced-by-count":4,"title":["Abnormal regulation of soluble and anchored IL-6 receptor in monocytes from patients with essential thrombocythemia"],"prefix":"10.1016","volume":"38","author":[{"given":"Nora P.","family":"Goette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola R.","family":"Lev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula G.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Glembotsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos D.","family":"Chazarreta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan P.","family":"Salim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felisa C.","family":"Molinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosana F.","family":"Marta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.exphem.2010.06.007_bib1","first-page":"S4","article-title":"Interleukin-6 in the pathogenesis of rheumatoid arthritis","volume":"65","author":"Park","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.exphem.2010.06.007_bib2","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/ibd.20148","article-title":"IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance","volume":"13","author":"Mudter","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.exphem.2010.06.007_bib3","first-page":"546","article-title":"The role of interleukin-6 and interleukin-6\/interleukin-6 receptor-\u03b1 complex in the pathogenesis of multiple myeloma","volume":"11","author":"Barill\u00e9","year":"2000","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.exphem.2010.06.007_bib4","first-page":"4653","article-title":"Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence","volume":"9","author":"Trikha","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2010.06.007_bib5","first-page":"210","article-title":"gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities","volume":"35","author":"Nakashima","year":"1998","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2010.06.007_bib6","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1172\/JCI26720","article-title":"Megakaryocyte biology and related disorders","volume":"115","author":"Pang","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2010.06.007_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.critrevonc.2007.11.003","article-title":"TPO-independent megakaryocytopoiesis","volume":"65","author":"Zheng","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.exphem.2010.06.007_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1189\/jlb.1105674","article-title":"Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer","volume":"80","author":"Rose-John","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.exphem.2010.06.007_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/jir.2005.25.241","article-title":"IL-6 transsignaling: the in vivo consequences","volume":"25","author":"Jones","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.exphem.2010.06.007_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/eji.1830230226","article-title":"The soluble interleukin-6 receptor is generated by shedding","volume":"23","author":"M\u00fcllberg","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2010.06.007_bib11","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.4049\/jimmunol.155.11.5198","article-title":"A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor","volume":"155","author":"Mullberg","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.exphem.2010.06.007_bib12","doi-asserted-by":"crossref","first-page":"38829","DOI":"10.1074\/jbc.M210584200","article-title":"Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE)","volume":"278","author":"Matthews","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2010.06.007_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.189.3.599","article-title":"C-reactive protein: a physiological activator of interleukin 6 receptor shedding","volume":"189","author":"Jones","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2010.06.007_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cytogfr.2006.09.003","article-title":"Interleukin-6 trans-signaling in inflammatory bowel disease","volume":"17","author":"Mitsuyama","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.exphem.2010.06.007_bib15","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood-2008-03-077966","article-title":"Myeloproliferative disorders","volume":"112","author":"Levine","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.06.007_bib16","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2010.06.007_bib17","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2010.06.007_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2010.06.007_bib19","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","article-title":"MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients","volume":"108","author":"Pardanani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.06.007_bib20","first-page":"657","article-title":"Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia","volume":"89","author":"Marta","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2010.06.007_bib21","first-page":"29","article-title":"Experience of Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment","volume":"34","author":"Murphy","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.exphem.2010.06.007_bib22","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.06.007_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by\u00a0acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1016\/j.exphem.2010.06.007_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9440(10)63312-3","article-title":"Interleukin-6\/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line","volume":"165","author":"Nakanishi","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.exphem.2010.06.007_bib25","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3514::AID-IMMU3514>3.0.CO;2-T","article-title":"Shedding of the soluble IL-6 receptor is triggered by Ca2+ mobilization, while basal release is predominantly the product of differential mRNA splicing in THP-1 cells","volume":"28","author":"Jones","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2010.06.007_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/intimm\/8.4.595","article-title":"The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi\u2019s sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth","volume":"8","author":"Murakami-Mori","year":"1996","journal-title":"Int Immunol"},{"key":"10.1016\/j.exphem.2010.06.007_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2353\/ajpath.2007.061078","article-title":"Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo","volume":"171","author":"Coles","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.exphem.2010.06.007_bib28","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1182\/blood.V93.8.2525","article-title":"Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling","volume":"93","author":"Sui","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2010.06.007_bib29","first-page":"540","article-title":"Megakaryopoietic cytokine levels in patients with essential thrombocythemia and their relationship with clinical and biochemical features","volume":"66","author":"Marta","year":"2006","journal-title":"Medicina"},{"key":"10.1016\/j.exphem.2010.06.007_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fj.99-1003rev","article-title":"The soluble interleukin 6 receptor: mechanisms of production and implications in disease","volume":"15","author":"Jones","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.exphem.2010.06.007_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/cyto.1996.0174","article-title":"A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells","volume":"9","author":"Gallea-Robache","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.exphem.2010.06.007_bib32","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.4049\/jimmunol.180.11.7102","article-title":"Soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells","volume":"180","author":"Briso","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2010.06.007_bib33","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ijc.21918","article-title":"Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): shedding of soluble IL-6R and activation of STAT3 signaling","volume":"119","author":"Horiuchi","year":"2006","journal-title":"Int J\u00a0Cancer"},{"key":"10.1016\/j.exphem.2010.06.007_bib34","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.170.5.1537","article-title":"Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes","volume":"170","author":"Bauer","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2010.06.007_bib35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/ncb1741","article-title":"A three-step pathway comprising PLZF\/miR-146a\/CXCR4 controls megakaryopoiesis","volume":"10","author":"Labbaye","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2010.06.007_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.232432399","article-title":"Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain","volume":"99","author":"Varghese","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2010.06.007_bib37","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1074\/jbc.M109.075952","article-title":"N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130","volume":"285","author":"Waetzig","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2010.06.007_bib38","first-page":"169","article-title":"Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status","volume":"91","author":"Arellano-Rodrigo","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2010.06.007_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00277-007-0386-3","article-title":"Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis","volume":"87","author":"Alvarez-Larr\u00e1n","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2010.06.007_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2141.1996.4631004.x","article-title":"Implication of CD44 in adhesion-mediated overproduction of TGF-beta and IL-1 in monocytes from patients with bone marrow fibrosis","volume":"93","author":"Rameshwar","year":"1996","journal-title":"Br J Haematol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X10002420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X10002420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T18:49:06Z","timestamp":1685645346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X10002420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0301472X10002420"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2010.06.007","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}